Tandem Diabetes Care Inc. Company Profile
NASDAQ: TNDMHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 10:33 AM ET
Tandem Diabetes Care at a glance
Tandem Diabetes Care Inc. (NASDAQ: TNDM) is a Medical/Dental Instruments company in the Health Care sector headquartered in San Diego, CA. Tandem Diabetes Care is led by Mr. John F. Sheridan and employs about 2,500 people. The company's shares have traded publicly since 2013.
At a market capitalization of $1.10 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001438133, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Tandem Diabetes Care do?
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Business description based on the company's public filings.
Company information
- Legal name
- Tandem Diabetes Care Inc.
- Ticker
- NASDAQ: TNDM
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. John F. Sheridan
- Employees
- 2,500
- Headquarters
- 12400 High Bluff Drive, San Diego, CA, United States
- Phone
- 858 366 6900
- Website
- tandemdiabetes.com
- IPO year
- 2013
- Market cap
- $1.10B
- SEC CIK
- 0001438133
- Latest annual report
- 10-K · Feb 19, 2026
Companies similar to Tandem Diabetes Care
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IRMDiRadimed Corporation | 86.53 | +0.76% | $1.11B | vs TNDM |
| IARTIntegra LifeSciences Holdings Corporation | 13.52 | +0.82% | $1.05B | vs TNDM |
| PRCTPROCEPT BioRobotics Corporation | 18.40 | +2.79% | $1.05B | vs TNDM |
| AORTArtivion Inc. | 21.29 | +0.38% | $1.04B | vs TNDM |
| BBNXBeta Bionics Inc. | 17.63 | +1.15% | $951.07M | vs TNDM |
| DRTSAlpha Tau Medical Ltd. | 14.30 | +2.11% | $1.32B | vs TNDM |
| BVSBioventus Inc. Class A | 12.90 | +1.62% | $880.79M | vs TNDM |
| SIBNSI-BONE Inc. | 19.19 | +1.75% | $860.07M | vs TNDM |